Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sarah Alexander currently holds 5,833 shares of NEWLINK GENETICS CORP (NLNK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah Alexander has been a net neutral trader of NLNK stock. They have purchased $0 and sold $0 worth of shares.
Sarah Alexander's most recent insider trade was on Nov 16, 2011, when they sold 542 shares at $0.00 per share.
Sarah Alexander serves as Executive at NEWLINK GENETICS CORP (NLNK). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Sarah Alexander holds the position of Executive at NEWLINK GENETICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Sarah Alexander has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sarah Alexander was on Nov 16, 2011, when they sold $0 worth of NLNK shares. This transaction involved 542 shares at N/A per share.
Sarah Alexander currently owns 5,833 shares of NEWLINK GENETICS CORP (NLNK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sarah Alexander's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sarah Alexander has 2 Form 4 filings on record as an insider at NEWLINK GENETICS CORP.
Set alerts for Sarah Alexander and 40,000+ other insiders.